Search Results for keywords:"contract proposals"

The National Heart, Lung, and Blood Institute has announced two upcoming meetings that will be closed to the public due to privacy and confidentiality concerns. These meetings, set for April 23, 2025, will involve reviewing and evaluating contract proposals and grant applications related to heart, lung, blood, and sleep disorders research. Both meetings will be held virtually at the National Institutes of Health in Bethesda, Maryland. The meetings are intended to discuss sensitive information such as trade secrets and personal data associated with the applications.

The National Institute of Allergy and Infectious Diseases will have a closed meeting on February 3, 2025, from 1:00 p.m. to 3:00 p.m., held via video conference at their Rockville, MD location. The session is closed to the public because it involves discussing confidential contract proposals that contain trade secrets, commercial property, or personal information. The meeting's purpose is to review and evaluate development proposals for medical treatments addressing non-tuberculosis mycobacterial infections. For more details, Dr. Mario Cerritelli serves as the contact person for further inquiries.

The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, announced that they will hold several closed meetings this February to review and evaluate contract proposals for developing pediatric formulations of tuberculosis drugs. These meetings are held under the Federal Advisory Committee Act and are closed to the public to protect confidential information and personal privacy. The meetings will be virtual, and they are occurring on February 22 and February 24, 2021, with participation led by Scientific Review Officer Mario Cerritelli. The announcements are being made less than 15 days before the meetings due to scheduling requirements aligned with the review and funding process.

The National Institute on Aging is holding a closed meeting on April 23, 2025, from 9:30 a.m. to 1:30 p.m. The meeting will be virtual and focus on reviewing and evaluating contract proposals. This information, including trade secrets and personal privacy for those involved, is being kept confidential as per federal regulations. More details can be obtained by contacting Dr. Maurizio Grimaldi at the National Institute on Aging.

The National Institute of Allergy and Infectious Diseases announced several closed meetings scheduled for February 1, 2021. These meetings will review and evaluate contract proposals related to adjuvants and vaccine discovery. The discussions are closed to the public to protect confidential information and personal privacy. Maggie A. Morris Fears, Ph.D., is the contact person for these meetings, which are part of the review and funding cycle activities.

The National Cancer Institute announced a series of closed meetings to review and evaluate grant applications and contract proposals. These meetings will occur virtually from February 24 to March 11, 2025, and involve discussions about potential confidential information. The confidentiality is due to concerns about disclosing trade secrets, commercial property, and personal information related to individuals connected with the proposals. Details for each meeting, including dates, times, and contact information, have been provided for transparency and record-keeping purposes.

The National Institute on Alcohol Abuse and Alcoholism (NIAAA) has announced a meeting that will be closed to the public to discuss contract proposals. This meeting will take place virtually on April 11, 2025, from 10:00 a.m. to 12:00 p.m. The purpose of the meeting is to review and evaluate proposals related to data science tools for accelerating alcohol research. The meeting is closed to protect confidential information and personal privacy.

The National Institute of Allergy and Infectious Diseases has announced a closed meeting scheduled for January 24, 2025, from 1:00 p.m. to 4:00 p.m. The meeting is closed to the public due to confidential discussions about contract proposals, which may include sensitive commercial information or personal data. This meeting involves the review and evaluation of proposals related to devices and materials-based platforms for delivering broadly neutralizing antibodies. The session will be held in Rockville, MD, but will be video-assisted, and Dr. Samita S. Andreansky will serve as the contact person for the meeting.

The National Institute on Alcohol Abuse and Alcoholism has announced a closed meeting of the Special Emphasis Panel to review and evaluate contract proposals. This meeting will take place on February 4, 2025, from 1:00 p.m. to 4:00 p.m. and will be conducted virtually. The discussion will involve confidential material, including trade secrets and personal information, which is why the meeting will not be open to the public. Interested parties should contact Dr. Beata Buzas for more information.

The National Cancer Institute has announced upcoming closed meetings to review grant applications and contract proposals. These meetings will be held virtually and will be closed to the public due to the sensitive nature of the information, which may include confidential trade secrets or personal information. Various meetings are scheduled from February 12 to March 20, 2025, focusing on different research topics such as cancer stigma, clinical and translational cancer research, and small business innovation research. Contact details for each meeting's scientific review officer are provided for further inquiries.